Methods and compositions for treatment of demyelinating diseases
US10085955B2 · kind B2 · utility
1Cited by
20References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2014 |
| Grant date | Oct 2, 2018 |
| Priority date | — |
| Expiry date | Jan 8, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are new oral pharmaceutical compositions of SAMDC inhibitors, polyamine analogs, and polyamine biosynthesis inhibitors, and their application for the treatment of conditions including demyelinating diseases, autoimmune disorders affecting the nervous system, and other neurodegenerative conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.